Piramal Enterprises Ltd has acquired over-the-counter dermatology brand Caladryl in India from Valeant Pharmaceuticals Inc, for an undisclosed amount. Caladryl is an anti-pruritic solution known for known for dermatosis application for minor skin irritations and itching.
The global brand was previously owned by Johnson & Johnson. Last year, Valeant acquired the rights for the brand from Johnson & Johnson.
Through this acquisition Piramal Enterprises will widen its consumer products portfolio in the skin care segment, the company announced in a press statement.
The current consumer products of Piramal Enterprises include Lacto Calamine, Saridon, i-Pill, Itchmosol and Supractiv Complete along with niche market brands like Polycrol, i-Sure, i-Can, Jungle Magic and Tetmosol.
Piramal Enterprises, part of diversified Piramal Group, had previously divested its domestic formulations business to Abbott but retained OTC products and drug discovery as a business. It has diversified itself beyond pharma and is now also into financial services domain.
(Edited by Joby Puthuparampil Johnson)
